Time point after treatment (days) | Number of consented eligible participants | Number of samples collected | Proportion positive for microscopy n(%) | Proportion positive for real-time PCR n(%) | Proportion positive for O-150 LAMP n(%) |
---|---|---|---|---|---|
D30 | 51 | 51 | 11 (21.6%) | 12 (23.5%) | 15 (29.4%) |
D90 | 51 | 51 | 12 (23.5%) | 16 (31.4%) | 19 (37.3%) |
D180 | 51 | 48 | 22 (45.8%) | 26 (54.2%) | 31 (64.6%) |
Total | Â | 150 | 45 (30%) | 54 (36.0%) | 65 (43.3%) |
Significance |  |  | P = 0.014 | P = 0.005 | P = 0.001 |